Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Elana Koss, MD
Hemal Gada, MD
New Hope for TAVR: Overcoming Challenges for Women & Patients With Small Annuli
Ashish Aneja, MD
Putting Data into Clinical Practice
Pam R. Taub, MD, FACC, FASPC
Steven Yakubov, MD, MSCAI, FACC
Challenging TAVR Cases
Renuka Jain, MD
Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data
Deepak Talreja, MD, FACC
Roxana Mehran, MD
Diagnosing HCM: What a cardiologist needs to know
Aleš Linhart, MD, PhD
HCM: Understanding the condition
Perry Elliott, MD
Emerging perspectives in the diagnosis and management of hypertrophic cardiomyopathy
Iacopo Olivotto, MD
Novel approaches in managing patients with HCM
Improving the management of patients with atherosclerotic cardiovascular disease - The evolving role of icosapent ethyl
Erik Stroes
P. Gabriel Steg, MD
Challenges in ASCVD reduction and TG-related risk
Perspectives on the results of recent clinical outcomes trials with EPA prevention
Integrating icosapent ethyl in cardiovascular risk reduction strategies: Practical guidance
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
Erin Michos
The evolving need and challenges to reach LDL-c targets in high-risk patients
Kausik Ray, MBChB, MD, MPhil
The LDL-c challenge in high cardiovascular risk - Integrating innovative therapies in clinical management
Lale Tokgözoğlu, MD
Fabrice Martens
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.